Related Experiment Videos
[Resection of liver metastases]
1Chirurgische Klinik mit Poliklinik, Universität Erlangen-Nürnberg.
Onkologie
|August 1, 1987
Summary
Liver resection for metastases significantly improves survival rates compared to no therapy. Advances in surgical techniques and technology have reduced mortality and increased the 5-year survival rate for colorectal cancer liver metastases to 32%.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastrointestinal Oncology
Context:
- Liver metastases significantly impact patient survival, with natural history survival rates as low as 0-3% at 5 years.
- Surgical resection of liver metastases has evolved significantly over decades.
- Early surgical interventions for liver metastases had high primary lethality rates.
Purpose:
- To evaluate the evolving outcomes of liver resection for metastases.
- To assess the impact of technological advancements on liver resection.
- To determine the current 5-year survival rate for curatively resected liver metastases in colorectal cancer.
Summary:
- Initial liver resections (1970-1983) showed high lethality (28% and 8%).
- Introduction of CUSA (Cavitational Ultrasonic Surgical Aspirator), intraoperative sonography, and segmental resection reduced lethality.
- Since 1984, with 110 resections, primary lethality dropped to 5%.
Impact:
- Improved surgical techniques and technology have drastically reduced mortality associated with liver resection.
- The 5-year survival rate for curatively resected colorectal cancer liver metastases has reached 32%.
- This demonstrates the increasing efficacy of surgical management for liver metastases.